Medios AG (ILM1D.XC)

14.72 0.00 (0.00%) At close: 02:30PM BST

Medios AG

Heidestrasse 9
Berlin 10557
Germany
49 30 232 5668 00
https://www.medios.ag

Sector(s): Healthcare
Industry: Medical Distribution
Full-time employees: 500

Description

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, parenteral nutrition solutions, and investigational medicinal products. Medios AG was founded in 2016 and is headquartered in Berlin, Germany.

Corporate governance

Medios AG’s ISS governance QualityScore as of 1 June 2024 is 1. The pillar scores are Audit: 3; Board: 2; Shareholder rights: 1; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.